The Global Needles Market is projected to reach USD 10.6 billion by 2027, at a CAGR of 6.7% during the forecast period. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer, HIV as well as growing elderly population. However, Growing focus on core development of substitute drug delivery methods is one of the challenge for which may inhibit the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930
Browse in-depth TOC on “Needles Market”
207– Tables
42 – Figures
220 – Pages
Key Market Players
The key players operating in this market are Becton, Dickinson, and Company (US), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), and Stryker Corporation (US).
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=223979930
Pen Needles in product segment to witness the highest growth rate during the forecast period.”
Based on the Product, the Needle Market is classified into Suture Needles, Blood Collection Needles, Ophthalmic Needles, Dental Needles, Insufflation Needles., By Pen Needles – Standard Needles, Safety Needles., By Biopsy and Aspiration Needles – Biopsy Needles, Core Biopsy Needles, Vaccum Assisted Needles Aspiration Needles, and Other Needles. The pen needles,segment is expected to dominate because of growing prevalence of diabetes as well as its wide range of availability in a of lengths and diameters moreover its used by doctors as well as patients to deliver injectable medications.
US dominates the North American Needles Market.
Based on the North America region, the Needles Market is divided into US and Canada. US is expected to dominate the Needles Market. Growing initiatives by different organizations for the reduction of blood-borne infections, and increasing prevalence of cardiovascular diseases., are the key factor driving market growth in the US.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=223979930
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/plasma-fractionation.asp
Related Reports:
